{
    "organizations": [],
    "uuid": "8a6d4daa5df801b86343b69e6c174644c318436b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-horizon-pharma-plc-announces-agree/brief-horizon-pharma-plc-announces-agreement-to-license-pre-clinical-uricase-derivative-from-medimmune-idUSFWN1P30IU",
    "ord_in_thread": 0,
    "title": "BRIEF-Horizon Pharma Plc Announces Agreement To License Pre-Clinical Uricase Derivative From Medimmune",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Horizon Pharma Plc:\n* HORIZON PHARMA PLC ANNOUNCES AGREEMENT TO LICENSE PRE-CLINICAL URICASE DERIVATIVE (MEDI4945) FROM MEDIMMUNE\n* HORIZON PHARMA PLC - WILL PROVIDE MEDIMMUNE AN UPFRONT CASH PAYMENT AND FUTURE PAYMENTS CONTINGENT ON MEDI4945 DEVELOPMENT AND SALES MILESTONES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T20:08:00.000+02:00",
    "crawled": "2018-01-09T16:56:53.042+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "horizon",
        "pharma",
        "plc",
        "horizon",
        "pharma",
        "plc",
        "announces",
        "agreement",
        "license",
        "uricase",
        "derivative",
        "medi4945",
        "medimmune",
        "horizon",
        "pharma",
        "plc",
        "provide",
        "medimmune",
        "upfront",
        "cash",
        "payment",
        "future",
        "payment",
        "contingent",
        "medi4945",
        "development",
        "sale",
        "milestone",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}